Three months ended
March 31,

2026

2025

Revaluation of investments, net:

Revaluation of Scilex, net (see note 4)

3,616

(3,617

)

Revaluation of Hapisga, net (see note 7)

6,969

-

Revaluation of Alpha Tau, net (see note 8)

36,433

-

Revaluation of RoyaltyVest loan, net (see note 6)

(130

)

-

Revaluation of Profit Sharing Loan Agreement (see note 4)

43

42

Revaluation of Convertible Note (see note 9)

(1,339

)

-

Revaluation of Marketable Securities (see note 3)

(1,691

)

254

Revaluation of Ruby Capital (see note 4)

(7

)

-

Revaluation of Lifeward (see note 9)

75

-

Gain on sale of marketable securities (see note 3)

754

-

44,723

(3,321

)

Interest Income

276

647

Exchange rate

(50

)

259

Other

(100

)

(143

)

$

44,849

$

(2,558

)